| 2023-12-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Research Officer | 10,000 0.0084% | $60.00 | $600,000 | -6.26% | |
| 2023-09-06 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Research Officer | 1,756 0.0015% | $43.01 | $75,526 | +15.2% | |
| 2022-05-27 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 10,000 0.0095% | $43.00 | $430,000 | +36.13% | |
| 2022-04-21 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 10,000 0.0079% | $43.00 | $430,000 | +3.91% | |
| 2022-04-05 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 1,218 0.0012% | $60.09 | $73,186 | -10.88% | |
| 2022-04-04 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 4,753 0.0044% | $57.18 | $271,788 | -9.55% | |
| 2022-04-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 22,992 0.0216% | $55.05 | $1.27M | -4.05% | |
| 2022-02-11 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 3,332 0.0034% | $46.80 | $155,938 | +10.03% | |
| 2022-02-10 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 20,000 0.0216% | $50.00 | $1M | +7.94% | |
| 2022-02-08 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 20,000 0.0202% | $45.00 | $900,000 | +12.09% | |
| 2022-01-31 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 2,466 0.0024% | $38.47 | $94,867 | +25.2% | |
| 2021-06-10 | Sale | Apellis Pharmaceuticals, Inc. APLS | CHIEF INNOVATION OFFICER | 6,834 0.0083% | $60.00 | $410,040 | -26.33% | |
| 2018-05-24 | Apellis Pharmaceuticals, Inc. APLS | See Remarks | 5,870 0.0108% | $20.37 | $119,572 | -10.08% |